CN110872292B - 一条合成糖尿病药物利拉利汀的路线 - Google Patents
一条合成糖尿病药物利拉利汀的路线 Download PDFInfo
- Publication number
- CN110872292B CN110872292B CN201911211881.0A CN201911211881A CN110872292B CN 110872292 B CN110872292 B CN 110872292B CN 201911211881 A CN201911211881 A CN 201911211881A CN 110872292 B CN110872292 B CN 110872292B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- preparation
- linagliptin
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911211881.0A CN110872292B (zh) | 2019-11-30 | 2019-11-30 | 一条合成糖尿病药物利拉利汀的路线 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911211881.0A CN110872292B (zh) | 2019-11-30 | 2019-11-30 | 一条合成糖尿病药物利拉利汀的路线 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110872292A CN110872292A (zh) | 2020-03-10 |
CN110872292B true CN110872292B (zh) | 2022-01-25 |
Family
ID=69717466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911211881.0A Active CN110872292B (zh) | 2019-11-30 | 2019-11-30 | 一条合成糖尿病药物利拉利汀的路线 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110872292B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2316551C1 (ru) * | 2006-12-26 | 2008-02-10 | Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) | Производные 3-метил-7-(тиетанил-3)ксантина, обладающие гемореологической активностью |
CN105936634A (zh) * | 2016-03-28 | 2016-09-14 | 赤峰赛林泰药业有限公司 | 一种利格列汀的合成方法 |
WO2019064214A1 (en) * | 2017-09-27 | 2019-04-04 | Biocon Limited | INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN |
-
2019
- 2019-11-30 CN CN201911211881.0A patent/CN110872292B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2316551C1 (ru) * | 2006-12-26 | 2008-02-10 | Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) | Производные 3-метил-7-(тиетанил-3)ксантина, обладающие гемореологической активностью |
CN105936634A (zh) * | 2016-03-28 | 2016-09-14 | 赤峰赛林泰药业有限公司 | 一种利格列汀的合成方法 |
WO2019064214A1 (en) * | 2017-09-27 | 2019-04-04 | Biocon Limited | INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN |
Non-Patent Citations (2)
Title |
---|
Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin;Zeng-Wei Lai等;《European Journal of Medicinal Chemistry》;20140623;第83卷;547-560 * |
Identification, isolation, characterization, and UHPLC quantification of potential genotoxic impurities in linagliptin;Yiwen Huang等;《J Sep Sci》;20181231;第41卷;3985–3994 * |
Also Published As
Publication number | Publication date |
---|---|
CN110872292A (zh) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU820659A3 (ru) | Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/ | |
JP6799178B2 (ja) | 4−メトキシピロール誘導体の中間体の製造方法 | |
US10538507B2 (en) | Preparation process for high-purity dabigatran etexilate | |
CN108569975B (zh) | 一种溴芬酸钠倍半水合物的制备方法 | |
CN110872292B (zh) | 一条合成糖尿病药物利拉利汀的路线 | |
SK14672001A3 (sk) | Spôsob syntézy a kryštalizácie zlúčenín obsahujúcich piperazínový kruh | |
CN105646446A (zh) | 一种纯化阿格列汀的方法 | |
CN103145636A (zh) | 一种1,4-二酰基-3,6-二苯基-1,4-二氢均四嗪类化合物及其制备方法和应用 | |
WO2022127327A1 (zh) | 一种博舒替尼1,3-丙二醚类二聚体杂质及其制备方法 | |
CN111548310B (zh) | 一种左西孟旦钠晶型及其制备方法 | |
JP6947354B2 (ja) | リナグリプチンの製造法 | |
JPS63295561A (ja) | 2−キノロン誘導体 | |
CN113620930A (zh) | 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用 | |
CN113461618A (zh) | 一种洛匹那韦的制备方法 | |
US8569322B2 (en) | Lamivudine oxalate and preparation method thereof | |
CN112679500B (zh) | 一种降糖药利格列汀中间体的制备方法 | |
CN114751853B (zh) | 6,6-二甲基-3-氮杂双环[3.1.0]己烷化合物的制备方法 | |
CN112176011B (zh) | 一种酶催化制备盐酸伐昔洛韦的方法 | |
KR101513561B1 (ko) | 펙소페나딘 염산염의 신규 제조방법 | |
CN107098842B (zh) | 一种维格列汀的纯化方法 | |
US20050143400A1 (en) | Process for preparing famciclovir | |
US20040266795A1 (en) | Process for the preparation of famciclovir | |
RU2741389C1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства | |
KR20110103711A (ko) | 신규 결정형의 자나미비어 수화물 및 이의 제조방법 | |
CN113956239A (zh) | 一种盐酸氮卓斯汀及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.38, Yangzi Road, ecological Chemical Technology Industrial Park, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co., Ltd Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant after: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. Address before: No.38, Yangzi Road, ecological Chemical Technology Industrial Park, Suqian City, Jiangsu Province Applicant before: JIANGSU JUNRUO PHARMACEUTICAL Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 223800 No. 38, Yangzi Road, Suqian ecological Chemical Technology Industrial Park, Suqian City, Jiangsu Province Applicant after: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant after: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant after: Nantong Baikang biomedical Co.,Ltd. Address before: 223800 No. 38, Yangzi Road, Suqian ecological Chemical Technology Industrial Park, Suqian City, Jiangsu Province Applicant before: Jiangsu junruo Pharmaceutical Co.,Ltd. Applicant before: Nanjing Junruo Biomedical Research Institute Co.,Ltd. Applicant before: HAIMEN BAIKANG PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |